PMID: 11912387Mar 26, 2002Paper

Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis

The Journal of Urology
Axel HeidenreichRolf Von Knobloch

Abstract

Lymphadenectomy for prostate cancer is limited to obturator and external iliac lymph nodes, although the internal lymph nodes represent the primary landing zone of lymphatic drainage. We performed anatomically adequate extended pelvic lymphadenectomy to assess the incidence of lymph node metastasis in cases of clinically localized prostate cancer. A total of 103 consecutive patients underwent extended pelvic lymphadenectomy at radical retropubic prostatectomy comprising 9 selective fields, namely the external iliac, internal iliac, obturator and common iliac lymph nodes bilaterally, and the presacral lymph nodes. Histopathological findings were compared with serum prostate specific antigen (PSA), histopathological stage, preoperative biopsy and postoperative prostatectomy Gleason score. Extended pelvic lymphadenectomy was compared with radical retropubic prostatectomy and standard lymphadenectomy in 100 consecutive patients in terms of complications, the number of lymph nodes dissected and operative time. There were no significant differences in age, preoperative PSA or mean biopsy Gleason score in patients who underwent extended pelvic and standard lymphadenectomy. Metastases were diagnosed in 27 of the 103 patients (26.2%) wh...Continue Reading

References

Oct 1, 1978·Seminars in Nuclear Medicine·C E Metz
Jan 1, 1976·British Journal of Urology·E P O'DonoghueG D Chisholm
Jan 1, 1987·Urologia Internationalis·T FujiokaS Okamoto
Jul 1, 1980·International Journal of Radiation Oncology, Biology, Physics·S O AsbellA S Baker
Jan 1, 1994·World Journal of Urology·H A FrazierD F Paulson
Aug 1, 1996·British Journal of Urology·J M Gil-Vernet
Oct 8, 1998·Urology·R E El-GalleyS D Graham

❮ Previous
Next ❯

Citations

May 5, 2005·Der Urologe. Ausg. A·M SchumacherU E Studer
May 14, 2005·Der Urologe. Ausg. A·F WawroschekD Weckermann
Oct 12, 2007·Der Urologe. Ausg. A·D WeckermannR Harzmann
Dec 18, 2008·Der Urologe. Ausg. A·T SchlommM Graefen
Jun 26, 2010·Der Urologe. Ausg. A·P AnheuserJ A Steffens
Mar 5, 2005·European Journal of Nuclear Medicine and Molecular Imaging·Isabelle Brenot-RossiDominique Rossi
May 12, 2009·European Journal of Nuclear Medicine and Molecular Imaging·G HollJ Sciuk
Mar 17, 2007·World Journal of Urology·Nivedita Bhatta DharUrs E Studer
Mar 29, 2008·World Journal of Urology·Fiona C Burkhard, Urs E Studer
Mar 30, 2010·World Journal of Urology·David SchillingArnulf Stenzl
Mar 21, 2013·World Journal of Urology·Michael A LissChristopher J Kane
Feb 24, 2007·International Journal of Colorectal Disease·M HaraT Kato
May 11, 2011·International Journal of Clinical Oncology·Jun Miki, Shin Egawa
Mar 12, 2011·Current Urology Reports·K A Keegan, M S Cookson
Sep 3, 2013·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·O ChapetF Lorchel
Nov 12, 2013·European Urology·Axel HeidenreichUNKNOWN European Association of Urology
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Sophie D FossåDag Rune Olsen
Sep 12, 2006·Nature Clinical Practice. Urology·Hartwig Huland
Jun 24, 2009·Prostate Cancer and Prostatic Diseases·J L SilbersteinC J Kane
Jul 16, 2010·Journal of Endourology·Alon Z Weizer, Jeffrey S Montgomery
Oct 4, 2012·Journal of Endourology·Yota YasumizuMototsugu Oya
Jan 11, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A HorwichUNKNOWN European Society for Medical Oncology
Mar 20, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F AbdollahA Briganti
Mar 26, 2011·American Journal of Clinical Oncology·Ellen W CookeJonathan D Tward
Nov 26, 2010·The American Journal of Surgical Pathology·Yuji TokudaSamson W Fine
Oct 19, 2011·Advances in Urology·Anthony Van BaelenSteven Joniau
Oct 5, 2011·Therapeutic Advances in Urology·Jan SchmitgesMarkus Graefen
Jul 4, 2008·Acta chirurgica Iugoslavica·J Bogdanovic, J Djozic
Jan 27, 2007·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Nebojsa JeremićVinka Maletić-Vuković
Jan 26, 2011·Nuklearmedizin. Nuclear Medicine·R SadeghiS R Zakavi
May 27, 2009·Indian Journal of Urology : IJU : Journal of the Urological Society of India·M EgawaS Terahata
Feb 19, 2010·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·Joseph L ChinAndrew Evans
Dec 31, 2010·Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada·D Robert Siemens
Apr 2, 2014·Advances in Urology·Daniar K OsmonovKlaus-Peter Jünemann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.